01 1Darmerica, LLC
02 4Hangzhou Sinodo Pharm Technology Co.,Ltd
03 1Hangzhou XinHan Biopharma Co., Ltd.
04 1LETCO MEDICAL, LLC
05 1Nanjing Xingyin Pharmaceutical Group Co. Ltd.
06 1Qingdao Biopeptek Co., Ltd.
07 1Zhejiang Peptites Biotech
01 1Sermorelin
02 8Sermorelin Acetate
03 1sermorelin acetate
01 2China
02 3U.S.A
03 5Blank
NDC Package Code : 73212-012
Start Marketing Date : 2020-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-056
Start Marketing Date : 2015-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2693
Start Marketing Date : 2008-07-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 70155-608
Start Marketing Date : 2017-12-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 73569-058
Start Marketing Date : 2024-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82907-762
Start Marketing Date : 2023-09-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 82907-762
Start Marketing Date : 2023-09-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 82907-762
Start Marketing Date : 2024-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 82907-762
Start Marketing Date : 2023-09-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 84789-106
Start Marketing Date : 2024-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Sermorelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sermorelin, including repackagers and relabelers. The FDA regulates Sermorelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sermorelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sermorelin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sermorelin supplier is an individual or a company that provides Sermorelin active pharmaceutical ingredient (API) or Sermorelin finished formulations upon request. The Sermorelin suppliers may include Sermorelin API manufacturers, exporters, distributors and traders.
click here to find a list of Sermorelin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sermorelin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sermorelin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sermorelin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sermorelin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sermorelin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sermorelin suppliers with NDC on PharmaCompass.
We have 5 companies offering Sermorelin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
